喘可能不是严重COVID-19疾病的潜在风险因素:一个范围审查
Chukwudi S Ubah1, Gregory D Kearney1, Lok R Pokhrel1
1Department of Public Health, Brody School of Medicine, East Carolina University, Greenville, NC, USA.
Environmental health insights
|January 8, 2024
概括
喘患者似乎没有增加2019年严重冠状病毒疾病 (COVID-19) 的风险. 大多数研究没有发现喘和严重的COVID-19结局之间的独立关联.
科学领域:
- 肺部病理学 肺部病理学
- 传染性疾病 传染性疾病
- 流行病学 流行病学
背景情况:
- 由SARS-CoV-2引起的2019年冠状病毒病 (COVID-19) 是一个重大的全球健康问题.
- 喘对COVID-19严重性的潜在影响一直是正在进行的调查的主题.
研究的目的:
- 进行现有文献的范围审查.
- 为了确定患有喘的患者与非喘患者相比,是否面临严重COVID-19疾病的风险更高.
主要方法:
- 对多个电子数据库进行了全面的搜索.
- 在范围审查过程中遵循了PRISMA指南.
- 采用了包含-排除标准,从最初的70篇,对21篇文章进行了深入分析.
主要成果:
- 大多数审查的研究 (21项中的17项) 发现喘和严重的COVID-19疾病之间没有独立的联系.
- 一小部分研究 (21项研究中的4项) 认为喘是潜在的危险因素.
结论:
- 目前的证据表明,喘可能不是严重COVID-19的重要风险因素.
- 建议进行进一步的大规模前性队列研究,以澄清喘在COVID-19严重性中的作用,并为临床指南提供信息.
相关概念视频
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma: Pathogenesis and Management
405
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
405
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Antiasthma Drugs: β2-Adrenoceptor Agonists
267
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
267
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K


